Clinical Trials List
2011-11-01 - 2012-12-31
Phase III
Terminated7
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 崔可忠 Division of Others
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Hsao-Hsun Hsu Division of General Surgery
- CHUN-TA HUANG Division of General Surgery
- 曾御慈 Division of General Surgery
- 許甯傑 Division of General Surgery
- CHIEN-HUA HUANG Division of Emergency Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- CHING-CHI Lee Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 李宗勳 無
- Chun-Hung Hua 無
- 鄭旭棠 無
- 周家卉 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 湯宏仁 Division of Infectious Disease
- Wei-Ting Chang Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Po-Liang Lu Division of Infectious Disease
- Chun-Yu Lin Division of Infectious Disease
- 林蔚如 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
70 participants
-
Global
556 participants
